Challenges Linger As Chinese Firms Kick Off R&D Race (Pt.1)
This article was originally published in PharmAsia News
Executive Summary
China's pharmaceutical industry is entering a critical period of transformation as it is losing its traditional price competitiveness in the international market and is now looking more to develop its potential as a force in original R&D. New development models and innovative firms have emerged in the country in recent years, and shared some of their strategies and challenges at a recent meeting in Shanghai.